Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

NCT00950274 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment stopped due to slow recruitment

Conditions

Myocardial Ischemia
Coronary Artery Disease

Interventions

DRUG: CD133+ autologous bone marrow stem cell
DRUG: Placebo

Sponsor

Miltenyi Biotec B.V. & Co. KG

Collaborators

[object Object]